August 11, 2008 -- Reliant Technologies Inc. (Mountain View, CA), developer of the Fraxel laser skin rejuvenation systems, has announced an agreement with Philips (Amsterdam, The Netherlands), the globally recognized consumer brand company. The agreement, which is now at an initial R&D stage, calls for the partners to develop skin care technologies for use in the home. It will combine Reliant's expertise in developing innovative skin rejuvenation laser treatments with Philips' design, marketing and global distribution capabilities.
According to Eric Stang, president and CEO of Reliant Technologies, "This exclusive partnership will allow us to leverage Reliant's unique fractional laser technology and enter the growing home use aesthetic market with innovative products that use the Philips and Fraxel brands."
According to the American Society of Aesthetic Plastic Surgeons, laser skin resurfacing is one of the fastest growing segments of the beauty industry having increased 230 percent from 1997 to 2007. In addition, more consumers have begun seeking home-use aesthetic treatments.
"The partnership with Philips continues the strong Reliant tradition of research and development that results in safe and effective products that fit our patients' lifestyles, whether in a physician's office or in the home," said Len DeBenedictis, Chief Technology Officer of Reliant Technologies. "Development of a home use device will complement the current portfolio of Fraxel laser systems by allowing consumers an introduction to Fraxel treatments and by offering a convenient touch up solution between professional Fraxel treatments."
Reliant Technologies develops clinical solutions to rejuvenate aging and environmentally damaged skin. The company pioneered the development of fractional laser resurfacing that relies on novel high-speed scanning systems and the Intelligent Optical Tracking system to produce safe and effective results with minimal recovery time. It owns the brand names Fraxel, whose product line includes the Fraxel re:pair, Fraxel re:store, and the Fraxel re:fine laser systems.
Reliant first won FDA 510(k) approval for its Fraxel systems in January 2008.